Quick Takeaways
- Laura Hamill has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $856,356.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Laura Hamill and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | Director | $771,297 | 07 Aug 2025 | ||
| ANAB, ANABV | ANAPTYSBIO, INC | Director | $85,059 | 06 Jan 2023 | ||
| YMAB | Y-mAbs Therapeutics, Inc. | Director | $0 | 16 Sep 2025 | ||
| XLRN | ACCELERON PHARMA INC | Director | 19 Nov 2021 | |||
| PRDS | PARDES BIOSCIENCES, INC. | Director | 31 Aug 2023 | |||
| SCLX, SCLXW | Scilex Holding Co | Director | 17 Jan 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|